Search research articles
Contact Us
Filters
Showing results (11-20 of 27) with videos related to
Page
of 3
Sort By:
Annals of Hematology
|
December 2, 2000
High-dose therapy with peripheral blood stem cell transplantation for patients with relapsed or refractory Hodgkin's disease: long-term outcome and prognostic factors
K Neben, S Hohaus, H Goldschmidt, et al.
International Journal of Hematology
|
May 10, 2011
Inflammatory autoimmune neuropathy, presumably induced by bortezomib, in a patient suffering from multiple myeloma
Stefan Schmitt, H Goldschmidt, B Storch-Hagenlocher, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 14, 2001
High plasma basic fibroblast growth factor concentration is associated with response to thalidomide in progressive multiple myeloma
K Neben, T Moehler, G Egerer, et al.
International Immunology
|
August 28, 1999
Impaired thymopoietic potential of immature CD3(-)CD4(+)CD8(-) T cell precursors from SIV-infected rhesus monkeys
K Neben, M Heidbreder, J Müller, et al.
Rofo : Fortschritte Auf Dem Gebiete Der Rontgenstrahlen Und Der Nuklearmedizin
|
September 4, 2004
[Dynamic MRI of the bone marrow for monitoring multiple myeloma during treatment with thalidomide as monotherapy or in combination with CED chemotherapy]
K Wasser, T Moehler, K Neben, et al.
International Journal of Cancer
|
August 24, 2001
Bone marrow microcirculation analysis in multiple myeloma by contrast-enhanced dynamic magnetic resonance imaging
T M Moehler, H Hawighorst, K Neben, et al.
Leukemia
|
October 3, 2003
Centrosome aberrations as a possible mechanism for chromosomal instability in non-Hodgkin's lymphoma
A Krämer, S Schweizer, K Neben, et al.
Der Radiologe
|
September 28, 2000
[Functional magnetic resonance tomography in the diagnosis and therapy monitoring in multiple myeloma]
T M Moehler, H Hawighorst, K Neben, et al.
Bone Marrow Transplantation
|
August 5, 2014
Bortezomib improves outcome after SCT in multiple myeloma patients with end-stage renal failure
I Breitkreutz, C Heiss, A Perne, et al.
International Journal of Hematology
|
April 26, 2013
Bisphosphonate treatment and renal function in 201 myeloma patients undergoing stem cell transplantation
S Schmitt, T Hielscher, C Baldus, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 27) with videos related to
Sort By:
Page
of 3
Annals of Hematology
|
December 2, 2000
High-dose therapy with peripheral blood stem cell transplantation for patients with relapsed or refractory Hodgkin's disease: long-term outcome and prognostic factors
K Neben, S Hohaus, H Goldschmidt, et al.
International Journal of Hematology
|
May 10, 2011
Inflammatory autoimmune neuropathy, presumably induced by bortezomib, in a patient suffering from multiple myeloma
Stefan Schmitt, H Goldschmidt, B Storch-Hagenlocher, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 14, 2001
High plasma basic fibroblast growth factor concentration is associated with response to thalidomide in progressive multiple myeloma
K Neben, T Moehler, G Egerer, et al.
International Immunology
|
August 28, 1999
Impaired thymopoietic potential of immature CD3(-)CD4(+)CD8(-) T cell precursors from SIV-infected rhesus monkeys
K Neben, M Heidbreder, J Müller, et al.
Rofo : Fortschritte Auf Dem Gebiete Der Rontgenstrahlen Und Der Nuklearmedizin
|
September 4, 2004
[Dynamic MRI of the bone marrow for monitoring multiple myeloma during treatment with thalidomide as monotherapy or in combination with CED chemotherapy]
K Wasser, T Moehler, K Neben, et al.
International Journal of Cancer
|
August 24, 2001
Bone marrow microcirculation analysis in multiple myeloma by contrast-enhanced dynamic magnetic resonance imaging
T M Moehler, H Hawighorst, K Neben, et al.
Leukemia
|
October 3, 2003
Centrosome aberrations as a possible mechanism for chromosomal instability in non-Hodgkin's lymphoma
A Krämer, S Schweizer, K Neben, et al.
Der Radiologe
|
September 28, 2000
[Functional magnetic resonance tomography in the diagnosis and therapy monitoring in multiple myeloma]
T M Moehler, H Hawighorst, K Neben, et al.
Bone Marrow Transplantation
|
August 5, 2014
Bortezomib improves outcome after SCT in multiple myeloma patients with end-stage renal failure
I Breitkreutz, C Heiss, A Perne, et al.
International Journal of Hematology
|
April 26, 2013
Bisphosphonate treatment and renal function in 201 myeloma patients undergoing stem cell transplantation
S Schmitt, T Hielscher, C Baldus, et al.
Page
of 3